HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday, 25 March 2013

Recent CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  12 papers were listed this time. Here's a few in our areas of research interest:

Rombach SM, Hollak CE, Linthorst GE, et al. Cost-effectiveness of enzyme replacement therapy for Fabry disease.  Orphanet J Rare Dis. 2013 Feb 19;8(1):29. [Epub ahead of print] PMID: 23421808

de Groot NL, van Haalen HG, Spiegel BM, et al. Gastroprotection in Low-Dose Aspirin Users for Primary and Secondary Prevention of ACS: Results of a Cost-Effectiveness Analysis Including Compliance. Cardiovasc Drugs Ther. 2013 Feb 16. [Epub ahead of print] PMID: 23417566

Magnuson EA, Farkouh ME, Fuster V, et al. Cost-Effectiveness of Percutaneous Coronary Intervention With Drug Eluting Stents Versus Bypass Surgery for Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease: Results From the FREEDOM Trial. Circulation. 2013 Feb 19;127(7):820-31. Epub 2012 Dec 31.